相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Special issue The advance of solid tumor research in China: Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response
Xi Tian et al.
INTERNATIONAL JOURNAL OF CANCER (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Regulation of Ferroptosis by Amino Acid Metabolism in Cancer
Jian Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Amino Acid Metabolism in Cancer Drug Resistance
Hee-Chan Yoo et al.
CELLS (2022)
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
Yuanyuan Qu et al.
NATURE COMMUNICATIONS (2022)
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
Wei Li et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2022)
A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
Jiaqi Su et al.
FRONTIERS IN ONCOLOGY (2022)
Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
Wenhao Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma
Wenhao Xu et al.
DISCOVER ONCOLOGY (2022)
Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations
Qiaofei Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
Wenhao Xu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo
Fan Feng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients
Ji Hyun Kim et al.
THORACIC CANCER (2020)
Large-scale public data reuse to model immunotherapy response and resistance
Jingxin Fu et al.
GENOME MEDICINE (2020)
L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of Gi- Protein- Coupled Receptors
Eileen Tremmel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Revised Exon Structure of l-DOPA Decarboxylase (DDC) Reveals Novel Splice Variants Associated with Colorectal Cancer Progression
Pinelopi Artemaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Dopamine inhibits human CD8+Treg function through D1-like dopaminergic receptors
Giorgia Nasi et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
Wen-Hao Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Kidney Cancer, Version 2.2017 Clinical Practice Guidelines in Oncology
Robert J. Motzer et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases
M. Levite
ACTA PHYSIOLOGICA (2016)
Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Zhaoyong Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Radiotherapy: Changing the Game in Immunotherapy
Sandra Demaria et al.
TRENDS IN CANCER (2016)
Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma
Tian Qin et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Dopamine receptors - IUPHAR Review 13
Jean-Martin Beaulieu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer
Georgios Koutalellis et al.
BJU INTERNATIONAL (2012)
Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells
Eleftherios Sachlos et al.
CELL (2012)
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression
Latif A. Wafa et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer
Margaritis Avgeris et al.
CLINICAL BIOCHEMISTRY (2008)
Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2004)
Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system
LA Wafa et al.
BIOCHEMICAL JOURNAL (2003)